Metraipolis › archive › dc_b5ef83e98259

Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study — Europe PMC PMID:41930310

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41930310
DOI
10.1016/j.esmorw.2025.100659
License (as archived)
solo-consultazione
Archived
2026-11-07T01:06:15.827Z
SHA-256 of the archived text
45e7a9562c2680313b6f052b1cd4120998865a2da30dca750899e8e02dd6da98
Stable URL of this page
https://metraipolis.com/documento/dc_b5ef83e98259

How to cite

Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study — Europe PMC PMID:41930310 — Europe PMC (en), https://europepmc.org/article/MED/41930310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ef83e98259 (Metraipolis archive dc_b5ef83e98259, sha256 45e7a9562c2680313b6f052b1cd4120998865a2da30dca750899e8e02dd6da98)
BibTeX
@misc{dcb5ef83e98259,
  title = {Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study — Europe PMC PMID:41930310},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41930310},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ef83e98259; sha256 45e7a9562c2680313b6f052b1cd4120998865a2da30dca750899e8e02dd6da98},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41930310. Agents can read the archived copy with the MCP tool read_document.